ADARx Pharmaceuticals, Inc.
NASDAQ:ADRXBiotechnology
Healthcare
$12.82 +0.73%
+$0.13 today
- Market cap
- $1.42B
- Beta
- 0.00
52W Low $16.64High $23.21
Volume 0.65M
Average 1.06M
Income Statement
Follow revenue through to earnings.
Revenue
—
Operating Income
—
Net Income
—
Income Statement
Currency unavailable
ADRX Earnings Waterfall · TTM
NASDAQ:ADRX · Revenue to Net Income
No earnings data available.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 8-K | Current report | Nov 12, 2026 | |
| SC 13G | SC 13G filing | Oct 16, 2026 | |
| SC 13D | SC 13D filing | Oct 5, 2026 |
Continue the stock analysis
Jump to another research area for this company.